To: Board of Supervisors
From: DHHS: Behavioral Health
Agenda Section: Consent
SUBJECT:
title
Professional Services Agreement with Diamond Drugs, Inc. Regarding the Provision of Pharmaceutical and Prescription Monitoring Services
end
RECOMMENDATION(S):
Recommendation
That the Board of Supervisors:
1. Approve, and authorize the Chair of the Board to execute, the attached professional services agreement with Diamond Drugs, Inc. regarding the provision of pharmaceutical and prescription monitoring services for the period of July 1, 2020 through June 30, 2022;
2. Authorize the Department of Health and Human Services - Behavioral Health Director, or a designee thereof, to execute any and all subsequent amendments to the attached professional services agreement with Diamond Drugs, Inc. after review and approval by County Counsel, Risk Management and the County Administrative Office; and
3. Direct the Clerk of the Board to return one fully executed original copy of the attached professional services agreement with Diamond Drugs, Inc. to the Department of Health and Human Services - Contract Unit for further processing.
Body
SOURCE OF FUNDING:
Behavioral Health Fund
DISCUSSION:
The Department of Health and Human Services - Behavioral Health (DHHS - Behavioral Health) is responsible for providing all necessary medications to the County of Humboldt’s behavioral health facilities, including, without limitation, DHHS - Behavioral Health’s psychiatric health facility, crisis stabilization unit and medication support clinics, the Humboldt County Correctional Facility, the Humboldt County Regional Facility and the Humboldt County Juvenile Hall. As a result, DHHS - Behavioral Health has historically contracted with licensed pharmacies, including, without limitation, Diamond Drugs, Inc., to provide necessary pharmaceutical and prescription monitoring services.
Diamond Drugs, Inc. provides comprehensive pharmaceutical services for prescription and non-prescription medication and medical supplies required at DHHS - Behavioral Health facilities. Diamond Drugs, Inc. delivers quality care for patients and clients by utilizing cost-effective innovative technologies, including, without limitation, computerized medication administration records, real-time reports and invoicing, which streamline service delivery and accountability. Additionally, Diamond Drugs, Inc. provides consultant pharmacists who are available for emergency and routine consultations 24 hours per day, 7 days per week. Prior to filling prescription orders, Diamond Drugs, Inc. screens each patient’s complete computerized medication profile to ensure safe and therapeutic medication administration.
Diamond Drugs, Inc. also works with DHHS - Behavioral Health staff and the Humboldt County Pharmacy and Therapeutics Committee to evaluate additions or deletions to DHHS - Behavioral Health’s psychotropic formulary. Diamond Drugs, Inc. provides quarterly medication usage reports accompanied with graphs, cost comparisons and drug indication for particular drug classes.
On Oct. 16, 2018 (Item C-12), the Board of Supervisors approved the current professional services agreement with Diamond Drugs, Inc. regarding the provision of pharmaceutical and prescription monitoring services for the period of July 1, 2018 through June 30, 2020. The attached professional services agreement will allow DHHS - Behavioral Health clients to continue receiving required pharmaceutical and prescription monitoring services from Diamond Drugs, Inc. for the period of July 1, 2020 through June 30, 2022.
Accordingly, DHHS - Behavioral Health recommends that the Board approve, and authorize the Chair of the Board to execute, the attached professional services agreement with Diamond Drugs, Inc. regarding the provision of pharmaceutical and prescription monitoring services for the period of July 1, 2020 through June 30, 2022. It is also recommended that the Board authorize the DHHS - Behavioral Health Director, or a designee thereof, to execute any and all subsequent amendments to the attached professional services agreement with Diamond Drugs, Inc., after review and approval by County Counsel, Risk Management and the County Administrative Office, in order to avoid any unnecessary delays in the provision of needed pharmaceutical prescription and monitoring services.
FINANCIAL IMPACT:
The attached professional services agreement with Diamond Drugs, Inc. has a maximum amount payable of $400,000 for the period of July 1, 2020 through June 30, 2022. In no event shall the maximum amount paid under the attached professional services agreement with Diamond Drugs, Inc. exceed $200,000 per fiscal year for FY’s 2020-2021 and 2021-2022. However, in the event local, state or federal funding is reduced or eliminated, the County of Humboldt may reduce the above-referenced maximum amount payable or terminate the attached professional services agreement with Diamond Drugs, Inc. in its entirety.
Expenditure appropriations related to the attached professional services agreement with Diamond Drugs, Inc. have been included in the proposed FY 2020-2021 budgets for DHHS - Behavioral Health budget units 1170-427, 1170-495 and 1170-498. Funding for the attached professional services agreement with Diamond Drugs, Inc. is available through Medi-Cal financial participation, state realignment and Mental Health Services Act revenues received by DHHS - Behavioral Health. As a result, approval of the attached professional services agreement with Diamond Drugs, Inc. will not impact the Humboldt County General Fund.
STRATEGIC FRAMEWORK:
The recommended actions support the Board of Supervisors’ Strategic Framework by ensuring continued opportunities for improved health and safety, protecting vulnerable populations and providing community-appropriate levels of service.
OTHER AGENCY INVOLVEMENT:
None
ALTERNATIVES TO STAFF RECOMMENDATIONS:
The Board could choose not to approve the attached professional services agreement with Diamond Drugs, Inc. regarding the provision of pharmaceutical and prescription monitoring services. However, this alternative is not recommended since it will not allow DHHS - Behavioral Health to provide necessary medications to its clients as required by state law.
ATTACHMENTS:
1. Professional Services Agreement with Diamond Drugs, Inc. Regarding the Provision of Pharmaceutical and Prescription Monitoring Services for Fiscal Years 2020-2021 through 2021-2022
PREVIOUS ACTION/REFERRAL:
Board Order No.: C-18, C-6, C-27, C-6, C-7, C-12
Meeting of: 6/24/14, 4/21/15, 6/23/15, 6/7/16, 5/9/17, 10/16/18
File No.: 18-1021; 20-649